NCT04609163

Brief Summary

Congenital Diaphragmatic Hernia (CDH) is characterized by an incomplete diaphragm formation, resulting in poor lung development (pulmonary hypoplasia), associated with altered vascularization of the lung (pulmonary hypertension), with respiratory and cardiovascular insufficiency at birth. Mortality and morbidity are extremely variable. Several efforts have been done to identify possible prenatal and postnatal indicators which could accurately predict patients' prognosis and to promote an individualized management. However, to date the accuracy of these factors with respect to the prediction of survival and disease severity still has limits. In the last years, there has been an impressive development of new research methodologies based on the artificial intelligence, also in the neonatal field. The Machine Learning (ML) method explores the possibility of building algorithms starting from the acquisition of relevant clinical data, and using them to make predictions or take decisions. Nevertheless, the ML method has never been applied to predict patient's outcome in newborns with CDH so far. Moreover, with the available tools, a reliable prediction on patient's risk of developing severe postnatal PH is not feasible. Our hypothesis is that the use of ML approach, based on multivariate analysis of different clinical pre- and postnatal variables, could allow the development of algorithms able to accurately predict patient's outcome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8.8 years until next milestone

First Submitted

Initial submission to the registry

October 20, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 12, 2024

Status Verified

November 1, 2024

Enrollment Period

10.8 years

First QC Date

October 20, 2020

Last Update Submit

November 9, 2024

Conditions

Keywords

congenital diaphragmatic herniapulmonary hypertensionbig datamachine learning

Outcome Measures

Primary Outcomes (1)

  • Prediction of suprasystemic pulmonary hypertension

    The main objective of the study is to develop a model to identify prenatally CDH patients who will develop suprasystemic PH, assessed in the time frame from birth to 48 hours after surgery and at discharge from the NICU.

    from birth to 48 hours after birth

Secondary Outcomes (4)

  • Prediction of death

    from birth up to 24 weeks

  • Prediction of extracorporeal membrane oxygenation (ECMO)

    from birth up to 24 weeks

  • Prediction of favorable response to extracorporeal membrane oxygenation (ECMO)

    from birth up to 24 weeks

  • Prediction of favorable response to Fetoscopic Endotracheal Occlusion (FETO)

    from birth up to 24 weeks

Interventions

retrospective data collection

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with CDH born between January 2016 and April 2020 will be considered for the study and will be enrolled according to the inclusion/exclusion criteria reported.

You may qualify if:

  • Inborn patients, born between 01/01/2012 and 31/12/2020, admitted to the NICU at birth;
  • Prenatal diagnosis of CDH;
  • Take charge of the mother with CDH fetus at a gestational age below or equal to 30+6 weeks at our Fetal Surgery Center.

You may not qualify if:

  • Outborn patients;
  • Lack of prenatal diagnosis of CDH;
  • Mother with CDH fetus not taken in charge at our Fetal Surgery Center;
  • Prenatal or postnatal diagnosis of non-isolated CDH, thus associated with genetic or malformative anomalies known to have an impact on patients' survival;
  • Twin pregnancies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Conte L, Amodeo I, De Nunzio G, Raffaeli G, Borzani I, Persico N, Griggio A, Como G, Colnaghi M, Fumagalli M, Cascio D, Cavallaro G. A machine learning approach to predict mortality and neonatal persistent pulmonary hypertension in newborns with congenital diaphragmatic hernia. A retrospective observational cohort study. Eur J Pediatr. 2025 Mar 11;184(4):238. doi: 10.1007/s00431-025-06073-0.

  • Conte L, Amodeo I, De Nunzio G, Raffaeli G, Borzani I, Persico N, Griggio A, Como G, Cascio D, Colnaghi M, Mosca F, Cavallaro G. Congenital diaphragmatic hernia: automatic lung and liver MRI segmentation with nnU-Net, reproducibility of pyradiomics features, and a machine learning application for the classification of liver herniation. Eur J Pediatr. 2024 May;183(5):2285-2300. doi: 10.1007/s00431-024-05476-9. Epub 2024 Feb 28.

  • Amodeo I, De Nunzio G, Raffaeli G, Borzani I, Griggio A, Conte L, Macchini F, Condo V, Persico N, Fabietti I, Ghirardello S, Pierro M, Tafuri B, Como G, Cascio D, Colnaghi M, Mosca F, Cavallaro G. A maChine and deep Learning Approach to predict pulmoNary hyperteNsIon in newbornS with congenital diaphragmatic Hernia (CLANNISH): Protocol for a retrospective study. PLoS One. 2021 Nov 9;16(11):e0259724. doi: 10.1371/journal.pone.0259724. eCollection 2021.

MeSH Terms

Conditions

Hernias, Diaphragmatic, CongenitalHypertension, Pulmonary

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Congenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHernia, DiaphragmaticInternal HerniaHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsLung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Giacomo Cavallaro, MD, PhD

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 20, 2020

First Posted

October 30, 2020

Study Start

January 1, 2012

Primary Completion

November 1, 2022

Study Completion

December 1, 2022

Last Updated

November 12, 2024

Record last verified: 2024-11